- Home
- COF vs SYK Comparison
COF vs SYK Comparison
Compare COF & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COF | SYK |
|---|---|---|
| Founded | 1988 | 1941 |
| Country | United States | United States |
| Employees | 77100 | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.5B | 109.3B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | COF | SYK |
|---|---|---|
| Price | $188.57 | $308.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 14 |
| Target Price | $258.94 | ★ $415.57 |
| AVG Volume (30 Days) | ★ 4.0M | 2.8M |
| Earning Date | 04-21-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.68% | 1.12% |
| EPS Growth | N/A | ★ 8.25 |
| EPS | N/A | ★ 1.93 |
| Revenue | N/A | ★ $25,116,000,000.00 |
| Revenue This Year | $95.92 | $9.80 |
| Revenue Next Year | $4.90 | $8.44 |
| P/E Ratio | ★ $52.03 | $159.07 |
| Revenue Growth | N/A | ★ 11.16 |
| 52 Week Low | $174.98 | $281.00 |
| 52 Week High | $259.64 | $404.87 |
Technical Indicators
Market Signals| Indicator | COF | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 49.52 | 46.30 |
| Support Level | $187.88 | $281.00 |
| Resistance Level | $190.99 | $375.26 |
| Average True Range (ATR) | 4.28 | 8.57 |
| MACD | 0.36 | 1.72 |
| Stochastic Oscillator | 69.99 | 65.30 |
Price Performance
Historical ComparisonAbout COF Capital One Financial Corporation
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending. Following the acquisition of Discover in 2025, the firm also has a modest personal loan business, though credit card lending provides the majority of the bank's revenue.
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.